Our data show that the antitumor effects and survival rates were similar between the mc-oriP-IFNγ-treated and mc-CMV-IFNγ-treated groups in the C666-1 tumor model (p>0.05; Figure 5). The gene discussed is IFNG; the disease is neoplasm.